Shopping Cart
- Remove All
- Your shopping cart is currently empty
TC-MCH 7c is an oral, selectable and blood-brain barrier penetrating MCH1R antagonist with IC50 performance of 5.6 nM against hMCH1R, and TC-MCH 7c is a phenylpyridone derivative with MCH1R Ki of 3.4 nM against human. In mice, MCH1R Ki was 3.0 nM.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $95 | In Stock | |
5 mg | $289 | In Stock | |
10 mg | $415 | In Stock | |
25 mg | $636 | In Stock | |
50 mg | $858 | In Stock | |
100 mg | $1,150 | In Stock | |
500 mg | $2,310 | In Stock | |
1 mL x 10 mM (in DMSO) | $261 | In Stock |
Description | TC-MCH 7c is an oral, selectable and blood-brain barrier penetrating MCH1R antagonist with IC50 performance of 5.6 nM against hMCH1R, and TC-MCH 7c is a phenylpyridone derivative with MCH1R Ki of 3.4 nM against human. In mice, MCH1R Ki was 3.0 nM. |
Targets&IC50 | MCH1R (mouse):3.0 nM , MCH1R (mouse):3.0 nM, MCH1R (human):5.6 nM, MCH1R (human):3.4 nM (ki), MCH1R (human):(ki)3.4 nM , MCH1R (human):5.6 nM |
In vitro | In [Ca2+]i mobilization, TC-MCH 7c has an IC50 of 9.7 μM for MCH1R [1]. TC-MCH 7c has IC50s of 23 nM and 9.0 μM for FLIPR and hERG, respectively[2]. |
In vivo | In DIO mice model, TC-MCH 7c (oral; 3-30 mg/kg; once-daily for 1.5 months) shows excellent body weight reduction in a dose-dependent manner [1]. TC-MCH 7c(oral; 3 to 30mg /kg) and 30mg /kg at 2, 15 and 24 h were 5.1, 1.8 and 0.7 μM, respectively[2]. |
Molecular Weight | 408.47 |
Formula | C24H25FN2O3 |
Cas No. | 864756-35-4 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||||||||||||
Solubility Information | 1eq. HCl: 36.8 mg/mL (90.0 mM) DMSO: 55 mg/mL (134.65 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
1eq. HCl/DMSO
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.